Literature DB >> 7437650

4-Aminopyridine blockade of neuronal depressant responses to adenosine triphosphate.

M N Perkins, T W Stone.   

Abstract

1 Adenosine, adenosine monophosphate and adenosine triphosphate (ATP) depressed the firing rate of neurones in the rat cerebral cortex when applied by microinontophoresis. 2 4-Aminopyridine, also applied iontophoretically blocked the depressant effects of the purines, without affecting responses to gamma-aminobutyric acid (GABA). This blockade was effected against purine depressions of both spontaneous and glutamate-evoked activity, suggesting that the interaction occurred postsynaptically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437650      PMCID: PMC2044348          DOI: 10.1111/j.1476-5381.1980.tb08720.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Inhibition of the calcium-induced increase in the potassium permeability of human red blood cells by quinine.

Authors:  M Armando-Hardy; J C Ellory; H G Ferreira; S Fleminger; V L Lew
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

2.  The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine.

Authors:  E S Vizi; J Knoll
Journal:  Neuroscience       Date:  1976       Impact factor: 3.590

3.  Synaptic transmission in squid giant synapse after potassium conductance blockage with external 3- and 4-aminopyridine.

Authors:  R Llinás; K Walton; V Bohr
Journal:  Biophys J       Date:  1976-01       Impact factor: 4.033

4.  Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement.

Authors:  P Hedqvist; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

Review 5.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

6.  Depression of corticospinal cells by various purines and pyrimidines.

Authors:  J W Phillis; G K Kostopoulos; J J Limacher
Journal:  Can J Physiol Pharmacol       Date:  1974-12       Impact factor: 2.273

7.  Purinergic depression of neurons in different areas of the rat brain.

Authors:  G K Kostopoulos; J W Phillis
Journal:  Exp Neurol       Date:  1977-06       Impact factor: 5.330

8.  The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.

Authors:  B L Ginsborg; G D Hirst
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

9.  Possible feed-back inhibition of noradrenaline release by purine compounds.

Authors:  M A Enero; B Q Saidman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

10.  A comparison of the effects of adenosine triphosphate with noradrenaline and with the inhibitory potential of the guinea-pig taenia coli.

Authors:  T Tomita; H Watanabe
Journal:  J Physiol       Date:  1973-05       Impact factor: 5.182

View more
  5 in total

1.  Naltrexone potentiates 4-aminopyridine seizures in the rat.

Authors:  A Mihály; K Bencsik; T Solymosi
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

3.  Inhibitory effect of adenosine on transmission in sympathetic ganglia.

Authors:  K A Alkadhi; T R Brown; M H Sabouni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

4.  Nicotinamide adenine dinucleotide depresses synaptic transmission in the hippocampus and has specific binding sites on the synaptic membranes.

Authors:  C D Richards; C R Snell; P H Snell
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

5.  Adenosine actions on CA1 pyramidal neurones in rat hippocampal slices.

Authors:  R W Greene; H L Haas
Journal:  J Physiol       Date:  1985-09       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.